Product Pipeline

Takeda discloses ethical drugs under development that have reached phase 1 or higher status in at least one country among Japan, the U.S. and Europe every quarter of the year.

View latest portfolio

 

 

 

 

 Date of Preparation March 2016

 

Takeda Pharma